Vitrafy Life Sciences Appoints New Director

Barchart · 10/16/2025 17:22

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest announcement is out from Vitrafy Life Sciences Ltd. ( (AU:VFY) ).

Vitrafy Life Sciences Limited has announced the appointment of Leigh Farrell as a new director, effective from October 16, 2025. The initial director’s interest notice indicates that Leigh Farrell currently holds no relevant interests in securities, either as a registered holder or otherwise, and has no interests in contracts related to the company. This appointment is a procedural update and does not immediately impact the company’s operations or market positioning.

The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.

More about Vitrafy Life Sciences Ltd.

Average Trading Volume: 14,817

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$80.77M

Find detailed analytics on VFY stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.